CSF proteomic signature predicts progression to Alzheimer's disease dementia

CSF proteomic signature predicts progression to Alzheimer's disease dementia

Abstract Introduction Individuals in the Alzheimer's disease (AD) continuum with mild cognitive impairment (prodromal AD) are at increased risk to develop dementia. Still, underlying pathophysiological processes remain unclear. We studied whether cerebrospinal fluid (CSF) proteome changes are r...

Full description

Bibliographic Details
Main Authors: Eleonora M. Vromen, Marta del Campo Milán, Philip Scheltens, Charlotte E. Teunissen, Pieter Jelle Visser, Betty M. Tijms
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease
cerebrospinal fluid
mild cognitive impairment
prognosis
proteomics
Online Access:https://doi.org/10.1002/trc2.12240

Internet

https://doi.org/10.1002/trc2.12240

Similar Items